BIOMAT Database Logo BIOMAT Database Logo

Proceedings: Chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. 1976

F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin

UI MeSH Term Description Entries
D011217 Practolol A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS. Dalzic,Eralzdin Practolol,ICI-50172,ICI 50172,ICI50172,Practolol, Eralzdin
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000526 Alprenolol One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent. 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol,Alfeprol,Alpheprol,Alprenolol Hydrochloride,Aptin,Aptin-Duriles,Aptina,Aptine,H-56-28,Aptin Duriles,AptinDuriles,H 56 28,H5628

Related Publications

F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Beta-adrenergic blockade in congestive cardiomyopathy.
May 1980, Lancet (London, England),
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Haemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathy.
September 1979, British heart journal,
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Beta blockade in congestive cardiomyopathy.
March 1981, American heart journal,
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
beta-Blockade and congestive cardiomyopathy.
March 1981, Lancet (London, England),
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Beta-adrenergic blockage in congestive cardiomyopathy.
May 1980, Lancet (London, England),
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Selective (beta-1) blockade in congestive cardiomyopathy.
May 1983, American heart journal,
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
beta-adrenergic receptor blockade in chronic heart failure.
February 2000, Circulation,
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.
September 1981, Lancet (London, England),
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.
January 1991, Heart and vessels. Supplement,
F Waagstein, and A Hjalmarson, and E Varnauskas, and I Wallentin
Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
January 1984, Journal of the American College of Cardiology,
Copied contents to your clipboard!